Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LFSTNYSE:OSHNASDAQ:PRVANASDAQ:RGEN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLFSTLifeStance Health Group$6.04-0.3%$6.35$4.64▼$8.61$2.35B1.31.59 million shs2.40 million shsOSHOak Street Health$39.00$37.57$13.29▼$39.00$9.52B2.235.76 million shsN/APRVAPrivia Health Group$23.07-1.1%$23.37$16.37▼$26.09$2.81B0.87738,291 shs596,352 shsRGENRepligen$121.18-1.1%$129.03$102.97▼$182.52$6.81B1.21739,589 shs515,449 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLFSTLifeStance Health Group+10.38%+3.95%-7.20%-19.31%+6.32%OSHOak Street Health0.00%0.00%0.00%0.00%0.00%PRVAPrivia Health Group+2.01%-4.89%+0.65%-3.08%+34.72%RGENRepligen+3.72%-3.96%-15.34%-24.73%-22.52%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLFSTLifeStance Health Group2.3329 of 5 stars3.41.00.00.03.32.50.6OSHOak Street HealthN/AN/AN/AN/AN/AN/AN/AN/APRVAPrivia Health Group3.4746 of 5 stars3.52.00.00.02.93.31.9RGENRepligen4.9033 of 5 stars4.32.00.04.54.03.31.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLFSTLifeStance Health Group 2.83Moderate Buy$8.5040.73% UpsideOSHOak Street Health 0.00N/AN/AN/APRVAPrivia Health Group 3.07Buy$27.7720.37% UpsideRGENRepligen 2.64Moderate Buy$173.2542.97% UpsideCurrent Analyst Ratings BreakdownLatest OSH, LFST, PRVA, and RGEN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2025PRVAPrivia Health GroupJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$29.00 ➝ $32.005/27/2025LFSTLifeStance Health GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$8.505/27/2025PRVAPrivia Health GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$23.00 ➝ $24.005/5/2025RGENRepligenHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$180.00 ➝ $180.004/30/2025RGENRepligenRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$202.00 ➝ $189.004/29/2025RGENRepligenJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$200.00 ➝ $190.004/29/2025RGENRepligenWolfe ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradePeer Perform ➝ Outperform$160.004/28/2025PRVAPrivia Health GroupJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$29.00 ➝ $29.004/16/2025RGENRepligenCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$170.00 ➝ $150.004/15/2025PRVAPrivia Health GroupRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$24.00 ➝ $26.004/10/2025PRVAPrivia Health GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$21.00 ➝ $23.00(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLFSTLifeStance Health Group$1.28B1.83N/AN/A$3.77 per share1.60OSHOak Street Health$2.16B4.40N/AN/A($1.10) per share-35.45PRVAPrivia Health Group$1.80B1.56$0.23 per share98.24$5.14 per share4.49RGENRepligen$650.43M10.47$2.26 per share53.61$35.19 per share3.44Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLFSTLifeStance Health Group-$186.26M-$0.10N/AN/AN/A-7.90%-6.66%-4.51%8/14/2025 (Estimated)OSHOak Street Health-$509.20M-$2.21N/AN/AN/A-23.57%N/A-25.08%N/APRVAPrivia Health Group$23.08M$0.12230.7285.443.470.75%2.02%1.21%8/14/2025 (Estimated)RGENRepligen$35.60M-$0.45N/A51.354.54-4.64%4.21%2.94%7/29/2025 (Estimated)Latest OSH, LFST, PRVA, and RGEN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/29/2025Q1 2025RGENRepligen$0.35$0.39+$0.04$0.10$163.65 million$169.17 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLFSTLifeStance Health GroupN/AN/AN/AN/AN/AOSHOak Street HealthN/AN/AN/AN/AN/APRVAPrivia Health GroupN/AN/AN/AN/AN/ARGENRepligenN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLFSTLifeStance Health Group0.191.321.32OSHOak Street HealthN/A1.411.41PRVAPrivia Health GroupN/A1.781.78RGENRepligen0.2610.448.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLFSTLifeStance Health Group85.50%OSHOak Street Health92.04%PRVAPrivia Health Group94.48%RGENRepligen97.64%Insider OwnershipCompanyInsider OwnershipLFSTLifeStance Health Group3.20%OSHOak Street Health11.55%PRVAPrivia Health Group10.70%RGENRepligen1.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLFSTLifeStance Health Group6,640388.88 million357.39 millionOptionableOSHOak Street Health6,000244.00 million215.82 millionNot OptionablePRVAPrivia Health Group810121.92 million102.96 millionOptionableRGENRepligen2,02056.18 million55.36 millionOptionableOSH, LFST, PRVA, and RGEN HeadlinesRecent News About These CompaniesUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $33.88 Million Stock Position in Repligen Co. (NASDAQ:RGEN)May 28 at 4:48 AM | marketbeat.comRepligen Announces Publication of the Company’s 2024 Corporate Sustainability ReportMay 27 at 10:20 AM | finance.yahoo.comRepligen Announces Publication of the Company's 2024 Corporate Sustainability ReportMay 27 at 8:00 AM | investing.comRepligen Announces Publication of the Company's 2024 Corporate Sustainability ReportMay 27 at 7:30 AM | globenewswire.comRepligen Co. (NASDAQ:RGEN) Shares Bought by Two Sigma Advisers LPMay 24, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Shares Sold by AWM Investment Company Inc.May 23, 2025 | marketbeat.comTeza Capital Management LLC Sells 10,705 Shares of Repligen Co. (NASDAQ:RGEN)May 23, 2025 | marketbeat.comRepligen Corporation to Present at William Blair Growth ConferenceMay 22, 2025 | uk.finance.yahoo.comTwo Sigma Investments LP Lowers Stake in Repligen Co. (NASDAQ:RGEN)May 22, 2025 | marketbeat.comPoint72 Asia Singapore Pte. Ltd. Trims Stock Position in Repligen Co. (NASDAQ:RGEN)May 22, 2025 | marketbeat.comNuveen Asset Management LLC Decreases Stock Position in Repligen Co. (NASDAQ:RGEN)May 22, 2025 | marketbeat.comPolar Asset Management Partners Inc. Buys 3,000 Shares of Repligen Co. (NASDAQ:RGEN)May 20, 2025 | marketbeat.comGotham Asset Management LLC Has $965,000 Stake in Repligen Co. (NASDAQ:RGEN)May 20, 2025 | marketbeat.comRepligen Co. (NASDAQ:RGEN) Receives $173.25 Average Price Target from AnalystsMay 20, 2025 | americanbankingnews.comRepligen Co. (NASDAQ:RGEN) Given Average Recommendation of "Moderate Buy" by AnalystsMay 19, 2025 | marketbeat.comBank of America Corp DE Trims Holdings in Repligen Co. (NASDAQ:RGEN)May 18, 2025 | marketbeat.comCritical Survey: Repligen (NASDAQ:RGEN) versus Maze Therapeutics (NASDAQ:MAZE)May 18, 2025 | americanbankingnews.comPoint72 Asset Management L.P. Has $132.23 Million Stake in Repligen Co. (NASDAQ:RGEN)May 17, 2025 | marketbeat.comInsider Sell: Anthony Hunt Sells 26,447 Shares of Repligen Corp (RGEN)May 17, 2025 | gurufocus.comRepligen Holds Annual Shareholders Meeting, Key Decisions MadeMay 15, 2025 | tipranks.comIntegral Health Asset Management LLC Purchases New Holdings in Repligen Co. (NASDAQ:RGEN)May 14, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOSH, LFST, PRVA, and RGEN Company DescriptionsLifeStance Health Group NASDAQ:LFST$6.04 -0.02 (-0.33%) Closing price 04:00 PM EasternExtended Trading$6.02 -0.01 (-0.25%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.Oak Street Health NYSE:OSHOak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.Privia Health Group NASDAQ:PRVA$23.07 -0.25 (-1.07%) Closing price 04:00 PM EasternExtended Trading$23.07 0.00 (0.00%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.Repligen NASDAQ:RGEN$121.18 -1.36 (-1.11%) Closing price 04:00 PM EasternExtended Trading$121.06 -0.12 (-0.10%) As of 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? Qualcomm Stock Turns South: 3 Entry Signals to Watch For D-Wave Quantum Stock: Are Advantage2 Gains Here to Stay? Meta's Institutional & Insider Data Fuels Bulls Despite Disparity Is Michael Burry Right Betting Against the Market Again? Amer Sports: The New ONON and DECK of Consumer Discretionary? BigBear.ai: Risky AI Stock or Defense Tech Opportunity? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
